Liquid chromatography-tandem mass spectrometry assay of reduced and oxidized glutathione and main precursors in mice liver

被引:57
作者
Bouligand, J
Deroussent, A
Paci, A [1 ]
Morizet, J
Vassal, G
机构
[1] Inst Gustave Roussy, UPRES, EA3535 Pharmacol & New Canc Treatments, Villejuif, France
[2] Univ Paris 11, Villejuif, France
[3] Inst Gustave Roussy, Mass Spectrometry Platform, IFR 54, Villejuif, France
[4] Inst Gustave Roussy, Dept Clin Pharm, Villejuif, France
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2006年 / 832卷 / 01期
关键词
HPLC-MS/MS; glutathione; disulfide glutathione; glutathione precursors; liver; mice;
D O I
10.1016/j.jchromb.2005.12.037
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A liquid chromatography/tandem mass spectrometry assay of glutathione (GSH), glutathione disulfide (GSSG) and of precursors (gamma-glutamylcysteine, cysteinyl-glycine, cysteine, cystine, homocysteine and homocystine) was developed to study glutathione synthesis in mice liver. After iodoacetic acid derivatization, the analytes were analyzed using reversed-phase gradient HPLC and detected using multiple reaction monitoring. Linear calibrations were performed over the concentrations range of 100-10,000 ng/rnL for the thiol-containing precursors and extended up to 100,000 ng/mL for GSH and GSSG. The method was validated for each compound with inter-day accuracy below 11.9% and with precision below 15%. The method showed low limits of quantitation of 100 ng/mL for each thiol-containing compound and GSSG and of 200 ng/mL for other disulfides. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:67 / 74
页数:8
相关论文
共 31 条
[1]   Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C [J].
Adinolfi, LE ;
Ingrosso, D ;
Cesaro, G ;
Cimmino, A ;
D'Antò, M ;
Capasso, R ;
Zappia, V ;
Ruggiero, G .
HEPATOLOGY, 2005, 41 (05) :995-1003
[2]   A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR REDUCED AND OXIDIZED GLUTATHIONE IN EMBRYONIC, NEONATAL, AND ADULT TISSUES USING A POROUS GRAPHITE ELECTROCHEMICAL DETECTOR [J].
CARROCIAMPI, G ;
HUNT, PG ;
TURNER, CJ ;
WELLS, PG .
JOURNAL OF PHARMACOLOGICAL METHODS, 1988, 19 (01) :75-83
[3]   Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice [J].
Chanas, SA ;
Jiang, Q ;
McMahon, M ;
McWalter, GK ;
McLellan, LI ;
Elcombe, CR ;
Henderson, CJ ;
Wolf, CR ;
Moffat, GJ ;
Itoh, K ;
Yamamoto, M ;
Hayes, JD .
BIOCHEMICAL JOURNAL, 2002, 365 (02) :405-416
[4]   Cellular target of cyclophosphamide toxicity in the murine liver: Role of glutathione and site of metabolic activation [J].
DeLeve, LD ;
Wang, XD ;
Huybrechts, MM .
HEPATOLOGY, 1996, 24 (04) :830-837
[5]   A simultaneous liquid chromatography/mass spectrometric assay of glutathione, cysteine, homocysteine and their disulfides in biological samples [J].
Guan, XM ;
Hoffman, B ;
Dwivedi, C ;
Matthees, DP .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 31 (02) :251-261
[6]   Changes in the intracellular homocysteine and glutathione content associated with aging [J].
Hernanz, A ;
Fernández-Vivancos, E ;
Montiel, C ;
Vazquez, JJ ;
Arnalich, F .
LIFE SCIENCES, 2000, 67 (11) :1317-1324
[7]   Determination of intracellular glutathione and thiols by high performance liquid chromatography with a gold electrode at the femtomole level: comparison with a spectroscopic assay [J].
Hiraku, Y ;
Murata, M ;
Kawanishi, S .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2002, 1570 (01) :47-52
[8]   Simultaneous determination of total plasma glutathione, homocysteine, cysteinylglycine, and methionine by high-performance liquid chromatography with electrochemical detection [J].
Houze, P ;
Gamra, S ;
Madelaine, I ;
Bousquet, B ;
Gourmel, B .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2001, 15 (03) :144-153
[9]   Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson's disease [J].
Hsu, M ;
Srinivas, B ;
Kumar, J ;
Subramanian, R ;
Andersen, J .
JOURNAL OF NEUROCHEMISTRY, 2005, 92 (05) :1091-1103
[10]  
*ICH Q2A, 1995, INT C HARM